Your browser doesn't support javascript.
loading
Association of free vitamin D3 concentrations and asthma treatment failures in the VIDA Trial.
Lima, John J; Castro, Mario; King, Tonya S; Lang, Jason E; Ortega, Victor E; Peters, Stephen P; Denlinger, Loren C; Israel, Elliot; Sorkness, Christine A; Wechsler, Michael E; Wenzel, Sally E; Smith, Lewis J.
Afiliação
  • Lima JJ; Nemours Children's Health System, Jacksonville, Florida. Electronic address: jlima@nemours.org.
  • Castro M; Washington University School of Medicine, St Louis, Missouri.
  • King TS; Penn State University, Hershey, Pennsylvania.
  • Lang JE; Duke University School of Medicine, Durham, North Carolina.
  • Ortega VE; Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Peters SP; Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Denlinger LC; University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Israel E; Brigham & Women's Hospital, Boston, Massachusetts.
  • Sorkness CA; Brigham & Women's Hospital, Boston, Massachusetts.
  • Wechsler ME; National Jewish Health, Denver, Colorado.
  • Wenzel SE; University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Smith LJ; Northwestern University, Chicago, Illinois.
Ann Allergy Asthma Immunol ; 121(4): 444-450.e1, 2018 10.
Article em En | MEDLINE | ID: mdl-29908319
ABSTRACT

BACKGROUND:

Use of vitamin D3 serum concentrations as a biomarker of vitamin D status is questionable because of variation in vitamin D binding protein.

OBJECTIVE:

To determine associations between free vitamin D3 concentrations and rates of treatment failure and exacerbations in patients with asthma participating in the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma (VIDA) trial.

METHODS:

Free concentrations were directly measured by enzyme-linked immunosorbent assay and stratified into low, medium, and high groups less than 5pg/mL (n = 65), 5 to 9pg/mL (n = 84), and greater than 9pg/mL (n = 48) after 12 weeks of supplementation with oral vitamin D3 and associated with outcomes.

RESULTS:

Outcomes did not associate with free concentrations overall treatment failure rates were 0.60 (95% confidence interval [CI] 0.46-0.78), 0.53 (95%CI 0.40- 0.70), and 0.69 (95%CI 0.54-0.90)/person-year (P = .51), respectively; overall exacerbation rates were 0.28 (95%CI 0.17-0.48), 0.15 (95%CI 0.08-0.30) and 0.42 (95%CI 0.27-0.66)/person-year (P = .22). Mean (standard deviation) baseline free concentrations were lower in non-Hispanic blacks and Hispanics compared with non-Hispanic whites 4.10 (1.33) and 4.38 (1.11) pg/mL vs 5.16 (1.65) pg/ml, (P < .001 and P = 0.038), respectively. Mean (standard deviation) baseline free concentrations differed between females and males 4.57 (1.58) and 5.08 (1.41) (P = .026); and between non-overweight (body mass index [BMI] < 25) and overweight (BMI > 25) 5.45 (1.86) vs 4.54 (1.39) (P < .001). The free fraction differed by race and sex but not by BMI.

CONCLUSION:

The use of free concentrations was inferior to total concentrations as a biomarker of efficacy of vitamin D3 supplementation in VIDA trial participants. Future studies of vitamin D status in patients with asthma should measure both free and total concentrations to better understand which marker of vitamin D function is most informative.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Fatores Sexuais / Falha de Tratamento / Colecalciferol / Suplementos Nutricionais Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Ann Allergy Asthma Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Fatores Sexuais / Falha de Tratamento / Colecalciferol / Suplementos Nutricionais Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Ann Allergy Asthma Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2018 Tipo de documento: Article